Common use of Term For Royalty Payment Clause in Contracts

Term For Royalty Payment. Royalties payable under Section 5.5.1 shall be paid on a country-by-country, and Product-by-Product basis with respect to Net Sales made during the “Royalty Term” for that country, which is defined as the period from the date of the First Commercial Sale of the Product until the later of: (i) the expiration of the last to expire, including any extensions thereto, Valid Claim of the Array Patents or ASLAN Patents claiming the manufacture, use or sale of the Product in the country where it was sold; or (ii) ten (10) years following the date of the First Commercial Sale of the Product in the country where the Product was sold.

Term For Royalty Payment. Royalties payable under Section 5.5.1 5.5 shall be paid on a country-by-country, and Product-by-Product basis with respect to Net Sales made during the “Royalty Term” for that country, which is defined as the period from the date of the First Commercial Sale of the Product until the later of: (i) the expiration of the last to expire, including any extensions thereto, expire Valid Claim of the Array Licensed Patents or ASLAN Oncothyreon Patents claiming the manufacture, use or sale of the Product in the country where it was sold; or (ii) ten (10) years following the date of the First Commercial Sale of the Product in the country where the Product was sold.

Term For Royalty Payment. Royalties payable under Section 5.5.1 10.3.1 or 10.4 shall be paid on a countrycountry‑by-by-country, and Product-by-Product country basis with respect to Net Sales made during the “Royalty Term” for that country, which is defined as the period from the date of the First Commercial Sale of the Product until the later of: (i) : 10.5.1 the expiration of the last to expire, including any extensions thereto, Valid Claim of expire Patent Rights within the Array Patents Technology, the Oncothyreon Technology or ASLAN Joint Patents claiming the manufacture, use or sale of the Product in the country where it was sold; or (ii) ten (10) years or 10.5.2 [*] following the date of the First Commercial Sale of the Product in the country where the Product was sold.

Term For Royalty Payment. Royalties payable under Section 5.5.1 5.5 shall be paid on a country-bycountry‑by-country, and Product-by-Product basis with respect to Net Sales made during the “Royalty Term” for that country, which is defined as the period from the date of the First Commercial Sale of the Product until the later of: (i) the expiration of the last to expire, including any extensions thereto, expire Valid Claim of the Array Licensed Patents or ASLAN Oncothyreon Patents claiming the manufacture, use or sale of the Product in the country where it was sold; or (ii) ten (10) years following the date of the First Commercial Sale of the Product in the country where the Product was sold.

Term For Royalty Payment. Royalties payable under Section 5.5.1 shall be paid on a country-by-country, and Product-by-Product basis with respect to Net Sales made during the “Royalty Term” for that country, which is defined as the period from the date of the First Commercial Sale of the Product until the later of: (i) the expiration of the last to expire, including any extensions thereto, Valid Claim of the Array Patents or ASLAN Patents claiming the manufacture, use or sale of the Product in the country where it was sold; or (ii) ten (10) years following the date of the First Commercial Sale of the Product in the country where the Product was sold.. ***Confidential Treatment Requested

Term For Royalty Payment. Royalties payable under Section 5.5.1 shall be paid on a country-bycountry‑by-country, and Product-by-Product basis with respect to Net Sales made during the “Royalty Term” for that country, which is defined as the period from the date of the First Commercial Sale of the Product until the later of: (i) the expiration of the last to expire, including any extensions thereto, Valid Claim of the Array Patents or ASLAN Patents claiming the manufacture, use or sale of the Product in the country where it was sold; or (ii) ten (10) years following the date of the First Commercial Sale of the Product in the country where the Product was sold.

Term For Royalty Payment. Royalties payable under Section 5.5.1 10.3.1 or 10.4 shall be paid on a country-by-country, and Product-by-Product country basis with respect to Net Sales made during the “Royalty Term” for that country, which is defined as the period from the date of the First Commercial Sale of the Product until the later of: (i) : 10.5.1 the expiration of the last to expire, including any extensions thereto, Valid Claim of expire Patent Rights within the Array Patents Technology, the Oncothyreon Technology or ASLAN Joint Patents claiming the manufacture, use or sale of the Product in the country where it was sold; or (ii) ten (10) years or 10.5.2 [*] following the date of the First Commercial Sale of the Product in the country where the Product was sold.